• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by GigCapital 5 Inc.

    7/6/22 4:57:33 PM ET
    $GIA
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $GIA alert in real time by email
    SC 13G 1 GIA_SC13G.htm SCHEDULE 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934

    GIGCAPITAL5, INC.
    (Name of Issuer)

    COMMON STOCK, PAR VALUE $0.0001 PER SHARE
    (Title of Class of Securities)

    37519U109
    (CUSIP Number)

    JUNE 27, 2022
    (Date of event which requires filing of this statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

         o Rule 13d-1(b)

         þ Rule 13d-1(c)

         o Rule 13d-1(d)

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).



                         
    CUSIP No.
     
    37519U109

    SCHEDULE 13G

    Page  
    2
      of   
    10

    1
     NAMES OF REPORTING PERSONS
     
     Millennium Management LLC
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   o
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     1,483,470
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     1,483,470
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,483,470
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     5.0%
    12 TYPE OF REPORTING PERSON

     
    OO


                         
    CUSIP No.
     
    37519U109

    SCHEDULE 13G

    Page  
    3
      of   
    10

    1
     NAMES OF REPORTING PERSONS
     
     Millennium Group Management LLC
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   o
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     1,483,470
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     1,483,470
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,483,470
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     5.0%
    12 TYPE OF REPORTING PERSON

     
    OO


                         
    CUSIP No.
     
    37519U109

    SCHEDULE 13G

    Page  
    4
      of   
    10

    1
     NAMES OF REPORTING PERSONS
     
     Israel A. Englander
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   o
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     1,483,470
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     1,483,470
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,483,470
    10
     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     5.0%
    12
     TYPE OF REPORTING PERSON

     IN

                         
    CUSIP No.
     
    37519U109

     SCHEDULE 13G

    Page  
    5
      of   
    10
     
    Item 1.    
     
    (a) Name of Issuer:
     
       
     
      GigCapital5, Inc.
     
       
     
    (b) Address of Issuer’s Principal Executive Offices:
     
       
     
     

    1731 Embarcadero Road, Suite 200
    Palo Alto, California 94303

         
    Item 2.
    (a) Name of Person Filing:
     
    (b) Address of Principal Business Office:
     
    (c) Citizenship:
         
     
      Millennium Management LLC
    399 Park Avenue
    New York, New York 10022
    Citizenship: Delaware
     
       
     
      Millennium Group Management LLC
    399 Park Avenue
    New York, New York 10022
    Citizenship: Delaware
     
       
     
      Israel A. Englander
    c/o Millennium Management LLC
    399 Park Avenue
    New York, New York 10022
    Citizenship: United States
     
       
      (d) Title of Class of Securities:
    common stock, par value $0.0001 per share ("Common Stock")
     
      (e) CUSIP Number:
    37519U109
     
     

    Item 3.  If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

     
      (a)   o   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
                 
     
      (b)   o   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
                 
     
      (c)   o   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
                 
     
      (d)   o   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
                 
     
      (e)   o   An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
                 
     
      (f)   o    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

                         
    CUSIP No.
     
    37519U109

     SCHEDULE 13G

    Page  
    6
      of   
    10
                 
     
      (g)   o   A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
                 
     
      (h)   o   A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
                 
     
      (i)   o   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
                 
     
      (j)   o   Group, in accordance with §240.13d-1(b)(1)(ii)(J).

    Item 4. Ownership

       Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    (a) Amount Beneficially Owned:

       See response to Item 9 on each cover page.

    (b) Percent of Class:   

       See response to Item 11 on each cover page.

     (c) Number of shares as to which such person has:

    (i) Sole power to vote or to direct the vote

       See response to Item 5 on each cover page.


                         
    CUSIP No.
     
    37519U109

     SCHEDULE 13G

    Page  
    7
      of   
    10

    (ii) Shared power to vote or to direct the vote

       See response to Item 6 on each cover page.

    (iii) Sole power to dispose or to direct the disposition of

       See response to Item 7 on each cover page.

    (iv) Shared power to dispose or to direct the disposition of

       See response to Item 8 on each cover page.

       The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

    Item 5. Ownership of Five Percent or Less of a Class

       If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

        Not applicable.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

        Not applicable.

    Item 8. Identification and Classification of Members of the Group

        See Exhibit I.

    Item 9. Notice of Dissolution of Group

        Not applicable.

    Item 10. Certification 

       By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


                         
    CUSIP No.
     
    37519U109

    SCHEDULE 13G

    Page  
    8
      of   
    10

    Exhibits:

    Exhibit I:  Joint Filing Agreement, dated as of July 5, 2022, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.


                         
    CUSIP No.
     
    37519U109

    SCHEDULE 13G

    Page  
    9
      of   
    10
                         
         

    SIGNATURE

                 

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

    Dated: July 5, 2022

    MILLENNIUM MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM GROUP MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    /s/ Israel A. Englander

    Israel A. Englander



                         
    CUSIP No.
     
    37519U109

    SCHEDULE 13G

    Page  
    10
      of   
    10
                         
          EXHIBIT I              
                         
          JOINT FILING AGREEMENT              

    This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.0001 per share, of GigCapital5, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

    Dated: July 5, 2022

    MILLENNIUM MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM GROUP MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    /s/ Israel A. Englander

    Israel A. Englander


    Get the next $GIA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GIA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GIA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Closing Date for Business Combination With QT Imaging

      QT Imaging Holdings, Inc. Expected to Begin Trading on Nasdaq Under Ticker Symbols "QTI" on March 5, 2024 GigCapital5, Inc. (("GigCapital5", NASDAQ:GIA), a Private-to-Public Equity (PPE)™ entity also known as special purpose acquisition company ("SPAC"), today announced that the completion of their previously announced business combination (the "Business Combination") with QT Imaging, Inc. ("QT Imaging"), a technology company engaged in an innovative automated breast imaging system producing high-resolution transmission ultrasound images, will take place on March 4, 2024. The Business Combination was approved at an Annual Meeting of GigCapital5's stockholders on February 20, 2024. Upon co

      2/29/24 4:45:00 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Shareholder Approval of Business Combination

      GigCapital5, Inc. ("GigCapital5") (NASDAQ:GIA) today announced that at the Annual Meeting of GigCapital5's stockholders (the "Annual Meeting") held on February 20, 2024, GigCapital5's stockholders voted to approve the previously announced proposed business combination between GigCapital5, QT Imaging, Inc. ("QT Imaging") and QTI Merger Sub, Inc. ("Merger Sub"), as well as all other proposals related to the Business Combination. GigCapital5 plans to file the results of the Annual Meeting, as tabulated by an independent inspector of elections, on Form 8-K with the Securities and Exchange Commission today. About GigCapital5 On December 8, 2022, GigCapital5 entered into a Business Combinat

      2/22/24 9:00:00 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:33:56 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:30:25 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by GigCapital 5 Inc. (Amendment)

      SC 13G/A - GigCapital5, Inc. (0001844505) (Subject)

      2/22/24 8:39:14 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Leadership Updates

    Live Leadership Updates

    See more
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    SEC Filings

    See more
    • SEC Form 8-K filed by GigCapital 5 Inc.

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/18/24 5:00:32 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Other Events

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/15/24 9:01:02 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/8/24 5:04:04 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Budagov Stas

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:36:16 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Weiner Zeev

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:18:19 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Dickson Daniel

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:17:06 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care